Personal tools

MCL coexpression mm9:756: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0354470656487682,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0570741246689917,0,0,0,0,0,0,0,0,0,0,0.0469568706916304,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.61386023570406,1.09245830946684,0,0,0,0.0719048733411253,0.0609639314262262,0.0285860945550467,0,0,0,0,0,0,0.0860734338295156,0.106546909924599,0.12977112683364,0.149700657682213,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0805006992779881,0,0,0.0266298923127834,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0663147875126409,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.695242579783572,0.257035567239424,0.457836599541483,0.683039380181079,0.914988014800803,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0857765460992942,0,0,0,0,0,0,0,0,0,0,0,0,0.0531569878936061,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0269518943326477,0.0242538736058389,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0766064454112358,0.0968441960560167,0.091291089277545,0,0,0.0865703124974023,0
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0354470656487682,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0570741246689917,0,0,0,0,0,0,0,0,0,0,0.0469568706916304,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.61386023570406,1.09245830946684,0,0,0,0.0719048733411253,0.0609639314262262,0.0285860945550467,0,0,0,0,0,0,0.0860734338295156,0.106546909924599,0.12977112683364,0.149700657682213,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0805006992779881,0,0,0.0266298923127834,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0663147875126409,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.695242579783572,0.257035567239424,0.457836599541483,0.683039380181079,0.914988014800803,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0857765460992942,0,0,0,0,0,0,0,0,0,0,0,0,0.0531569878936061,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0269518943326477,0.0242538736058389,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0766064454112358,0.0968441960560167,0.091291089277545,0,0,0.0865703124974023,0
|gostat_on_MCL_coexpression=GO:0003841;1-acylglycerol-3-phosphate O-acyltransferase activity;0.0423227250725998;28169!GO:0016411;acylglycerol O-acyltransferase activity;0.0423227250725998;28169!GO:0005212;structural constituent of eye lens;0.0423227250725998;12959!GO:0008374;O-acyltransferase activity;0.0423227250725998;28169!GO:0004907;interleukin receptor activity;0.0423227250725998;242700!GO:0019965;interleukin binding;0.0423227250725998;242700!
|gostat_on_MCL_coexpression=GO:0003841;1-acylglycerol-3-phosphate O-acyltransferase activity;0.0423227250725998;28169!GO:0016411;acylglycerol O-acyltransferase activity;0.0423227250725998;28169!GO:0005212;structural constituent of eye lens;0.0423227250725998;12959!GO:0008374;O-acyltransferase activity;0.0423227250725998;28169!GO:0004907;interleukin receptor activity;0.0423227250725998;242700!GO:0019965;interleukin binding;0.0423227250725998;242700!
|ontology_enrichment_celltype=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000014!8.70e-18!5;UBERON:0001003!8.70e-18!5;UBERON:0002097!8.70e-18!5;UBERON:0002199!8.70e-18!5;UBERON:0007029!8.70e-18!5;UBERON:0007376!8.70e-18!5;UBERON:0002416!8.70e-18!5;UBERON:0007383!8.70e-18!5;UBERON:0003102!2.41e-11!22;UBERON:0002102!6.71e-08!7;UBERON:0004710!6.71e-08!7;UBERON:0005419!6.71e-08!7;UBERON:0005417!6.71e-08!7;UBERON:0005729!6.71e-08!7;UBERON:0010708!6.51e-07!8
}}
}}

Revision as of 21:12, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:127100526..127100537,-p@chr10:127100526..127100537
-
Mm9::chr10:18127642..18127661,+p6@Nhsl1
Mm9::chr10:66997260..66997273,+p@chr10:66997260..66997273
+
Mm9::chr10:77783449..77783452,-p7@Agpat3
Mm9::chr11:120569386..120569404,+p@chr11:120569386..120569404
+
Mm9::chr11:120569415..120569431,+p@chr11:120569415..120569431
+
Mm9::chr4:135242197..135242216,+p4@Il28ra
Mm9::chr5:112680157..112680197,-p2@Cryba4
Mm9::chr9:26612030..26612042,-p@chr9:26612030..26612042
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:00038411-acylglycerol-3-phosphate O-acyltransferase activity0.0423227250725998
GO:0016411acylglycerol O-acyltransferase activity0.0423227250725998
GO:0005212structural constituent of eye lens0.0423227250725998
GO:0008374O-acyltransferase activity0.0423227250725998
GO:0004907interleukin receptor activity0.0423227250725998
GO:0019965interleukin binding0.0423227250725998



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
zone of skin8.70e-185
skin epidermis8.70e-185
skin of body8.70e-185
integument8.70e-185
surface8.70e-185
outer epithelium8.70e-185
integumental system8.70e-185
enveloping layer of ectoderm8.70e-185
surface structure2.41e-1122
forelimb6.71e-087
pectoral appendage6.71e-087
pectoral appendage bud6.71e-087
forelimb bud6.71e-087
forelimb/pectoral fin field6.71e-087
pectoral complex6.51e-078


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:756&oldid=2156564"